Japanese regenerative medicine company ReproCELL Inc., has acquired Scottish life sciences company, Biopta. The acquisition of Biopta and its U.S. subsidiary, Biopta Inc. is aimed at strengthening ReproCELL’s pharmaceutical industry-targeted drug discovery services. The acquisition will also see an immediate investment to expand Biopta’s range of contract research services. Biopta, which will continue to operate from its headquarters in Glasgow, aims to grow its workforce to 30 over the next thr...